Issues in the Cross-National Assessment of Health Technology

With the growing international literature in economic evaluation and the rapid spread of new health technologies, there is a need to undertake, or at least interpret, economic evaluations on the international level. However, the ways in which cross-national differences affect the cost-effectiveness of health technologies or their evaluations have never been studied. This paper explores these issues by taking advantage of a unique situation in which the same economic evaluation of a new indication for a health technology was conducted simultaneously in four countries using an identical methodology. The study showed that if prior agreement on methods can be reached and local data applied, economic evaluations can be undertaken in a way that facilitates the extrapolation of results from country to country.

[1]  M. Weinstein,et al.  Foundations of cost-effectiveness analysis for health and medical practices. , 1977, The New England journal of medicine.

[2]  G. Hammersen,et al.  Neonatal Screening for Inborn Errors of Metabolism , 1980, Springer Berlin Heidelberg.

[3]  A. M. O. Veale,et al.  Screening for Phenylketonuria , 1980 .

[4]  D L Sackett,et al.  Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep-vein thrombosis. , 1981, The New England journal of medicine.

[5]  K E Warner,et al.  Introduction to cost-benefit and cost-effectiveness analysis in health care. , 1982, Mead Johnson Symposium on Perinatal and Developmental Medicine.

[6]  P. Clifford,et al.  Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. , 1982, The New England journal of medicine.

[7]  S. Finkler.  The distinction between cost and charges. , 1982, Annals of internal medicine.

[8]  S. Horton,et al.  Cost-effectiveness and user characteristics of clinic based services for the treatment of diarrhea: a case study in Bangladesh. , 1983, Social science & medicine.

[9]  D. Graham,et al.  Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. , 1984, The New England journal of medicine.

[10]  J. Wang'ombe,et al.  Economic evaluation in primary health care: the case of Western Kenya community based health care project. , 1984, Social science & medicine.

[11]  D. Wingate.  Gastrointestinal disease: pathophysiology, diagnosis, management , 1984 .

[12]  M. Britton,et al.  Diagnosing Suspected Stroke: A Cost-Effectiveness Analysis , 1985, International Journal of Technology Assessment in Health Care.

[13]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[14]  S. Roth,et al.  PREVENTION OF NSAID-INDUCED GASTRIC ULCER WITH MISOPROSTOL: MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL , 1988, The Lancet.

[15]  A. T. Ghelijns.  Economic appraisal of health technology in the european community: by M.F. Drummond (Ed.) Oxford University Press, Oxford, 1987 265 pp., ISBN 0-19-261634-X, [pound sign]30.00 , 1988 .

[16]  U. Ma.  Economic analysis of the vaccination strategies adopted in Brazil in 1982. , 1988 .

[17]  B. Bloom,et al.  Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs. , 1989, Archives of internal medicine.

[18]  M. Drummond,et al.  Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs. , 1990, Postgraduate medical journal.